A simple blood draw measuring thyroid-stimulating hormone (TSH) is the standard first step for evaluating thyroid function, and for most people it is the only test needed. When TSH comes back abnormal, additional blood tests for thyroid hormones and antibodies help pin down the cause, while imaging and tissue sampling enter the picture when nodules or structural problems are suspected. The testing pathway is straightforward at its core but branches in several directions depending on what the initial results show.
Why TSH Comes First
Your thyroid gland does not operate independently. It takes orders from the pituitary gland, which releases TSH to tell the thyroid how much hormone to produce. When thyroid hormone levels drop, TSH rises to push the gland harder; when thyroid hormone levels climb too high, TSH falls. This feedback loop is tightly regulated by thyroid hormone itself acting on the brain regions that control TSH release.1PubMed Central. Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase Because TSH responds so sensitively to even small shifts in thyroid hormone, it picks up problems before the hormones themselves move outside their normal range.
A landmark strategy paper in The Lancet showed that when a sensitive TSH measurement comes back normal, the patient can be considered euthyroid (thyroid function is fine), and measuring thyroid hormones adds nothing useful. Only when TSH is elevated or suppressed do follow-up hormone measurements become necessary to distinguish between mild and full-blown thyroid dysfunction.2PubMed. A new strategy for thyroid function testing This “TSH-first” approach remains the backbone of thyroid testing worldwide, saving patients unnecessary blood draws and labs unnecessary work.
Most labs report a normal TSH range somewhere around 0.4 to 4.0 or 4.5 mIU/L, though the exact boundaries shift slightly between assay manufacturers. A result above the upper limit points toward hypothyroidism (an underactive thyroid), while a result below the lower limit suggests hyperthyroidism (an overactive thyroid). From there, the next step is measuring thyroid hormones directly.
Free T4 and Free T3
The thyroid produces two main hormones: thyroxine (T4) and triiodothyronine (T3). Most of both hormones ride through the bloodstream attached to binding proteins, especially one called thyroxine-binding globulin (TBG). Only the small fraction floating free can enter cells and do its job. That is why labs measure “free T4” and “free T3” rather than total amounts: free hormone levels reflect what is actually available to the body, while total levels can be thrown off by anything that changes binding protein concentrations.3PubMed. Free thyroid hormone measurement. A critical appraisal
Free T4 is ordered most often because T4 is the thyroid’s main output. If TSH is high and free T4 is low, you have overt hypothyroidism. If TSH is high but free T4 is still normal, that is subclinical hypothyroidism, a milder state where the pituitary is working harder to keep hormone levels in range. The same logic applies in reverse for hyperthyroidism: a suppressed TSH with high free T4 confirms overt hyperthyroidism, while a suppressed TSH with normal free T4 is subclinical.
Free T3 testing is less routine but matters in specific situations. Some patients with hyperthyroidism have a suppressed TSH and a normal free T4 but an elevated free T3, a pattern sometimes called T3 toxicosis. One study defined free T3 toxicosis specifically as a markedly suppressed TSH (at or below 0.1 mIU/L), a normal free T4, a normal total T3, evidence of a primary thyroid abnormality on scanning, and an elevated free T3.4The American Journal of Medicine. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis Without measuring free T3 in these cases, the diagnosis would be missed entirely.
Measuring free hormones is not always straightforward. Different lab methods handle binding protein interference differently, and some older techniques can over- or underestimate free T4 when TBG concentrations are very high or very low.5Clinical Chemistry. Dependence of Free Thyroxine Estimates Obtained with Equilibrium Tracer Dialysis on the Concentration of Thyroxine-Binding Globulin Pregnancy is the most common scenario where this becomes a practical problem, as discussed later in this article. For most non-pregnant adults, current free T4 assays are reliable enough that the distinction between methods rarely matters at the clinical level.
Thyroid Antibody Tests
Blood tests can also detect antibodies that the immune system produces against the thyroid, helping identify whether an autoimmune process is driving thyroid dysfunction. Three antibodies come up most often in clinical practice.
- TPO antibodies: Antibodies against thyroid peroxidase, an enzyme the thyroid needs to make hormones. These are the most commonly ordered thyroid antibodies and are elevated in the vast majority of people with Hashimoto’s thyroiditis, the leading cause of hypothyroidism. One study found anti-TPO antibodies in about 74% of Graves’ disease patients and over 99% of those with Hashimoto’s thyroiditis or a related condition called idiopathic myxedema.6The Journal of Clinical Endocrinology & Metabolism. Antithyroid Peroxidase Autoantibodies in Thyroid Diseases TPO antibodies are also useful for predicting whether someone with mildly elevated TSH will eventually progress to full hypothyroidism.7PubMed. Clinical and laboratory aspects of thyroid autoantibodies
- TSH receptor antibodies (TRAb): These antibodies bind the TSH receptor on thyroid cells and are the hallmark of Graves’ disease, the most common cause of hyperthyroidism. In Graves’ disease, stimulating TRAb mimic TSH and force the gland to overproduce hormones. Third-generation assays for TRAb have a sensitivity above 97% and specificity above 98% for identifying Graves’ disease.8PubMed Central. Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test A meta-analysis confirmed these numbers, finding that a TRAb-positive person is over a thousand times more likely to have Graves’ disease than a TRAb-negative person.9PubMed. TSH receptor autoantibody immunoassay in patients with Graves’ disease: improvement of diagnostic accuracy over different generations of methods
- Thyroglobulin antibodies (TgAb): Less commonly ordered for initial diagnosis, these are important in monitoring patients who have been treated for thyroid cancer. In the context of Hashimoto’s diagnosis, one study found TgAb positivity in about 96% of patients with biopsy-confirmed disease, making it a strong predictor of the histological diagnosis.10PubMed. Clinical significance of measurements of antithyroid antibodies in the diagnosis of Hashimoto’s thyroiditis: comparison with histological findings
Antibody testing is not part of a standard screening panel for everyone. It becomes relevant when blood tests show thyroid dysfunction and the doctor needs to determine whether autoimmune disease is the cause, or when monitoring a known autoimmune thyroid condition over time.
Thyroglobulin and Cancer Monitoring
Thyroglobulin (Tg) is a protein produced exclusively by thyroid tissue. After surgery and radioactive iodine treatment for differentiated thyroid cancer, the idea is that there should be essentially no thyroid tissue left, so Tg levels should drop to undetectable. If Tg starts rising afterward, it signals that cancer may be recurring. A serum Tg below 1 ng/mL while on thyroid hormone therapy by the second year after surgery is associated with a low five-year recurrence risk.11PubMed. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement
A more recent study of 268 patients looked at Tg levels at the one-year mark. Among patients with undetectable Tg at one year, the structural recurrence rate was only about 1%. In contrast, patients with detectable Tg at one year had a recurrence rate of 38%.12PubMed. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer This makes Tg monitoring invaluable for deciding how aggressively to follow up after thyroid cancer treatment. One wrinkle: TgAb can interfere with Tg measurements, so labs typically check for both simultaneously. If TgAb are present, the Tg result may be unreliable, and TgAb levels themselves can serve as a rough surrogate marker.
Thyroid Ultrasound
Ultrasound is the go-to imaging technique for evaluating the thyroid’s structure. It shows the size of the gland, whether nodules are present, and what those nodules look like. Not every nodule needs a biopsy, so classification systems help doctors decide which ones warrant further investigation. The ACR TI-RADS system, for example, assigns points based on features like composition, echogenicity, shape, and margins, then categorizes nodules from benign-appearing to highly suspicious.13PubMed Central. Ultrasound imaging classifications of thyroid nodules for malignancy risk stratification and clinical management: state of the art
Ultrasound works well for ruling out cancer in low-suspicion nodules. In a study evaluating ACR TI-RADS scoring against biopsy and surgical pathology, TI-RADS 3 nodules (mildly suspicious) that were not recommended for biopsy were truly benign about 95% of the time.14JAMA Network Open. Concordance of the ACR TI-RADS Classification With Bethesda Scoring and Histopathology Risk Stratification of Thyroid Nodules That kind of negative predictive value gives doctors and patients confidence in watching a low-risk nodule rather than jumping to a needle biopsy.
Radioactive Iodine Uptake and Thyroid Scans
When blood tests confirm hyperthyroidism, the next question is often why. A radioactive iodine uptake (RAIU) test helps answer that. The thyroid absorbs iodine to make hormones, so giving a small dose of radioactive iodine and measuring how much the gland takes up over a set period reveals whether the gland is overactive or whether excess hormone is coming from another source entirely.
High uptake typically points to Graves’ disease or a toxic nodular goiter, conditions where the thyroid itself is producing too much hormone. Low uptake, on the other hand, suggests thyroiditis (inflammation causing hormone to leak out of damaged cells), exogenous hormone intake, or other less common causes. Distinguishing between these matters because the treatments diverge sharply.15PubMed. Syndromes of thyrotoxicosis with low radioactive iodine uptake A thyroid scan taken at the same time produces an image showing whether uptake is diffuse (as in Graves’) or concentrated in one or a few spots (as in toxic nodules). One study found that RAIU reliably discriminated between euthyroid patients, those with subacute thyroiditis, and those with Graves’ disease, though for toxic nodules the scan image was necessary alongside the uptake number.16Journal of Nuclear Medicine Technology. Patterns of Thyroid Radioiodine Uptake: Jordanian Experience
Fine-Needle Aspiration Biopsy
When a nodule looks suspicious enough on ultrasound, a fine-needle aspiration (FNA) biopsy is the next step. A thin needle is guided into the nodule, usually under ultrasound, to extract cells for examination under a microscope. Results are reported using the Bethesda System, which classifies samples into six categories ranging from non-diagnostic to malignant. This system gives both the patient and the surgeon a clearer sense of the probability of cancer.
In studies correlating Bethesda categories with surgical pathology, malignancy rates climb steeply across the categories. One study reported malignancy rates of 0% for non-diagnostic samples, about 5% for benign, 20% for atypia of undetermined significance, about 31% for suspicious for follicular neoplasm, 75% for suspicious for malignancy, and nearly 98% for the malignant category.17PubMed Central. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up The overall diagnostic accuracy of FNA has been reported at roughly 88% to 97%, depending on the study and institution.18PubMed Central. The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study19PubMed Central. Evaluation of Thyroid Lesions by Fine-needle Aspiration Cytology According to Bethesda System and its Histopathological Correlation
The gray zone lies in the middle Bethesda categories, where the cytology is indeterminate, not clearly benign but not clearly malignant either. About 20% of thyroid nodules fall into this indeterminate range, and historically many of these patients ended up having diagnostic surgery just to get a definitive answer. Molecular testing has changed that. A randomized trial found that roughly half of patients with indeterminate nodules who underwent molecular testing had negative results and were able to avoid diagnostic surgery altogether.20JAMA Oncology. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial These molecular panels analyze the aspirated cells for genetic mutations and gene expression patterns associated with thyroid cancer, providing a second layer of information beyond what the microscope can see.
What Can Throw Off Your Results
Thyroid blood tests are generally reliable, but several factors can skew them in ways that mimic or mask real disease.
TSH itself fluctuates throughout the day. Levels peak overnight, roughly between 8 p.m. and 2 a.m., and hit their lowest point during the daytime hours.21Acta Endocrinologica. Studies on Circadian Variations of Plasma TSH, Thyroxine and Triiodothyronine in Man Season, age, body weight, smoking status, and even the presence of TPO antibodies in people with no thyroid symptoms can all nudge TSH levels up or down.22PubMed Central. Within-Person Variation in Serum Thyrotropin Concentrations: Main Sources, Potential Underlying Biological Mechanisms, and Clinical Implications This natural variability is one reason a single borderline TSH result often warrants a recheck before committing to a diagnosis.
Biotin supplements are a particularly sneaky confounder. Many thyroid immunoassays use a biotin-streptavidin reaction in their chemistry. If you are taking high-dose biotin (commonly marketed for hair, skin, and nails), excess biotin in your blood can interfere with these assays. In competitive-format assays used for free T3 and free T4, biotin causes falsely high readings. In sandwich-format assays used for TSH, biotin causes falsely low readings.23PubMed. Immunoassay design and biotin interference The combined effect, high free T4 plus low TSH, perfectly mimics hyperthyroidism on paper. Studies testing multiple analyzer platforms confirmed this pattern across commonly used instruments.24PubMed Central. Assessment of biotin interference in thyroid function tests Most labs now advise stopping biotin supplements at least two to three days before thyroid testing.
Several medications also alter thyroid test results. Amiodarone, a heart rhythm drug, is rich in iodine and disrupts thyroid function through multiple pathways, including blocking the conversion of T4 to T3. Lithium, used for bipolar disorder, concentrates in the thyroid and can inhibit hormone release, sometimes causing hypothyroidism. High-dose corticosteroids can suppress TSH and reduce T4-to-T3 conversion.25PubMed Central. How medications affect thyroid function If you are on any of these medications and your thyroid numbers look off, your doctor needs to factor in the drug effect before concluding that your thyroid itself is the problem.
Severe illness creates its own category of confusing results. Critically ill patients in the ICU often show low T3 and elevated reverse T3 (an inactive form of the hormone) without having true thyroid disease, a pattern known as non-thyroidal illness syndrome or “sick euthyroid syndrome.” TSH and T4 can also shift in prolonged illness. Serial testing that includes T3 and reverse T3 helps clinicians distinguish between actual thyroid dysfunction and these illness-related changes.26PubMed Central. Non-thyroidal illness (euthyroid sick) syndrome: Laboratory aspects and clinical significance in critically ill patients and other diseases – A narrative review
Thyroid Testing During Pregnancy
Pregnancy changes nearly every aspect of thyroid testing and interpretation. Rising estrogen levels boost TBG production, which increases total T4 and T3 concentrations even though free hormone levels remain stable. More importantly, human chorionic gonadotropin (hCG), the hormone that surges in early pregnancy, has a weak TSH-like effect on the thyroid. As hCG peaks in the first trimester, it stimulates the thyroid slightly and drives TSH down.27PubMed. The role of hCG in regulation of the thyroid gland in normal and abnormal pregnancy Using standard non-pregnant TSH reference ranges to interpret first-trimester results would flag many healthy pregnant women as hyperthyroid.
For this reason, trimester-specific reference ranges are recommended.28PubMed Central. Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals Earlier guidelines suggested an upper TSH limit of 2.5 mIU/L for the first trimester, but more recent data indicate that a more realistic cutoff is between 3.0 and 4.0 mIU/L depending on the lab assay used and the population studied.29PubMed Central. Reporting Thyroid Function Tests in Pregnancy The same review noted that ethnicity and iodine nutrition may also shift where that upper boundary falls. Free T4 assays present their own challenge in pregnancy because the elevated TBG can make certain assay methods less accurate, a point that has been well documented in the lab literature.30PubMed. Measurement of total rather than free thyroxine in pregnancy: the diagnostic implications
Getting thyroid assessment right in pregnancy matters because both overt and subclinical hypothyroidism have been linked to adverse obstetric outcomes and concerns about fetal brain development. The stakes are higher, and the normal ranges are moving targets, so testing and interpretation require extra care.
Newborn Screening
Congenital hypothyroidism, where a baby is born with an underactive or absent thyroid, affects roughly one in every two to four thousand newborns. Before routine screening began in the 1970s, most of these children were not diagnosed until months after birth, by which point irreversible neurological damage had often already occurred. Today, a heel-prick blood test within the first few days of life measures TSH (or in some programs, T4) and enables diagnosis and treatment typically within two weeks of birth.31PubMed Central. Newborn Screening for Congenital Hypothyroidism This is one of the clearest success stories in screening medicine, and newborn thyroid screening is now standard in virtually all developed countries.
At-Home Thyroid Test Kits
Direct-to-consumer thyroid test kits have become widely available, typically requiring a finger-prick blood sample mailed to a lab. The central question is whether capillary blood from a finger stick gives results comparable to a standard venous blood draw. A study using a digital immunoassay platform found strong correlations between capillary and venous blood for both TSH and free T4, with correlation coefficients of 0.99 and 0.97 respectively.32PubMed Central. Determination of Capillary Blood TSH and Free Thyroxine Levels Using Digital Immunoassay That is encouraging for the accuracy of the measurement itself.
The limitation of these kits is not usually the lab chemistry but the interpretation. Most at-home kits measure TSH alone, or TSH plus free T4. They will not tell you why your thyroid is off, and they do not include antibody testing, imaging, or clinical context. A borderline TSH result from an at-home kit still needs to be confirmed by a lab draw and interpreted by a clinician who knows your medical history, medications, and symptoms. These kits work best as a convenient first screen, particularly for people monitoring a known thyroid condition between doctor visits, rather than as a substitute for a full clinical workup.